BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.205
+0.035 (2.99%)
Jul 28, 2026, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 596.61 million as of July 28, 2026. Its market cap has decreased by -5.32% in one year.
Market Cap
596.61M
Enterprise Value
549.23M
Revenue
40.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.21
ChartMarket Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 596.61M, an increase of 692.53%. That is a compound annual growth rate of 10.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 596.61M | 18.14% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.44T |
| Genmab | 117.14B |
| Coloplast | 94.59B |
| Demant | 58.88B |
| ChemoMetec | 7.17B |
| Gubra | 5.81B |
| Pharma Equity Group | 103.36M |
| Scandinavian Medical Solutions | 85.09M |